You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell-Free Nucleic Acids

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Next-Generation-Sequencing Trial (Molecular genetic diagnostic)

Not yet recruiting
  • Next-Generation-Sequencing
  • Molecular genetic diagnostic
  • (no location specified)
May 12, 2023

Cell-Free Nucleic Acids, Biomarkers, Fluorescence Trial in Yangsan

Recruiting
  • Cell-Free Nucleic Acids
  • +3 more
    • Yangsan, Gyeongsangnam-do, Korea, Republic of
      Pusan National University Yangsan Hospital
    Jan 24, 2022

    Cell-Free Nucleic Acids Trial (Cell free DNA analysis)

    Not yet recruiting
    • Cell-Free Nucleic Acids
    • Cell free DNA analysis
    • (no location specified)
    Jan 27, 2022

    Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seoul (cell free DNA in blood and urine,

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • cell free DNA in blood and urine, metabolite/microbiome in urine and stool
    • Seoul, Korea, Republic of
    • +1 more
    Nov 2, 2022

    Cell Free Circulating Nucleic Acids as New Tumor Diagnostics

    Unknown status
    • New Tumor Diagnostics From Human Plasma Samples
      • Assiut, Egypt
        Assiut University Hospitals- Faculty of Medicine
      Sep 15, 2019

      Project CADENCE (CAncer Detected Early caN be CurEd)

      Recruiting
      • Thoracic Cancer
      • +8 more
        • Singapore, Singapore
          Biopollis, Helios
        Nov 21, 2022

        A Single-center, Prospective Cohort Study on Differentiation of

        Recruiting
        • Bile Duct Neoplasms
        • +2 more
        • cfDNA methylation detection
        • Xi'an, Shaanxi, China
          The First Affiliated Hospital of the Air Force Medical Universit
        Oct 30, 2023

        Hepatocellular Carcinoma, Desflurane Adverse Reaction, Propofol Adverse Reaction Trial in Hangzhou (Des?urane, Propofol)

        Completed
        • Hepatocellular Carcinoma
        • +3 more
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer hospital
        Aug 15, 2022

        Liquid Biopsy of Head and Neck Cancer Blood and Saliva

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
          • Munich, Germany
            Klinikum rechts der Isar der Technischen Universität München
          Nov 4, 2021

          NSCLC Trial in United States (erlotinib, bemcentinib)

          Completed
          • Non-Small Cell Lung Cancer
          • Los Angeles, California
          • +9 more
          Aug 16, 2022

          Premature Ovarian Insufficiency, Diminished Ovarian Reserve Trial (EV-Pure™)

          Not yet recruiting
          • Premature Ovarian Insufficiency
          • Diminished Ovarian Reserve
          • (no location specified)
          Oct 2, 2023

          PRediction Of Five Usual Tumors Using Blood Test for Risk

          Not yet recruiting
          • Neoplasms
          • Cancer
          • Multi-cancer early detection test
          • Guangzhou, Guangdong, China
            The Sixth Affiliated Hospital of Sun Yat-sen University
          May 16, 2023

          Ovarian Cancer Trial in Milwaukee (Pembrolizumab, Carboplatin, Paclitaxel)

          Active, not recruiting
          • Ovarian Cancer
          • Milwaukee, Wisconsin
            Medical College of Wisconsin and Froedtert Hospital
          Apr 7, 2022

          Genome Transplant Dynamics

          Recruiting
          • Thoracic Organ Transplantation
            • Baltimore, Maryland
            • +2 more
            Jul 21, 2022

            Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

            Not yet recruiting
            • Multiple Myeloma
            • Allogeneic Stem Cell Transplantation
            • CARTemis-1
            • Santander, Cantabria, Spain
            • +4 more
            Aug 1, 2023

            Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma

            Recruiting
            • Extensive Stage Lung Small Cell Carcinoma
            • +3 more
            • Biopsy
            • +4 more
            • Los Angeles, California
            • +8 more
            Jan 31, 2023

            Colorectal Cancer, Colon Polyp, Healthy Trial in Korea, Republic of (Earlytect Colon Cancer)

            Active, not recruiting
            • Colorectal Cancer
            • +2 more
            • Earlytect Colon Cancer
            • Busan, Korea, Republic of
            • +7 more
            Feb 27, 2022

            Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular

            Completed
            Has Results
            • Gliosarcoma
            • Recurrent Glioblastoma
            • Laboratory Biomarker Analysis
            • +2 more
            • Chicago, Illinois
              Northwestern University
            Aug 5, 2022

            Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)

            Recruiting
            • Sickle Cell Disease
            • +2 more
            • HDL2
            • Pointe-à-Pitre, Guadeloupe, France
            • +1 more
            Mar 21, 2023

            Hepatocellular Carcinoma Trial in Guangzhou (TCR-T, No intervention and TCR-T (at crossover))

            Completed
            • Hepatocellular Carcinoma
            • TCR-T
            • No intervention and TCR-T (at crossover)
            • Guangzhou, Guangdong, China
              The First Affiliated Hospital, Sun-Yat Sen University
            Jun 27, 2022

            Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL Trial in Memphis (biological,

            Recruiting
            • Acute Lymphoblastic Leukemia, in Relapse
            • +2 more
            • CD19-CAR(Mem) T-cells
            • +5 more
            • Memphis, Tennessee
              St. Jude Children's Research Hospital
            Aug 5, 2022

            Neurodegenerative Diseases Trial in Pozzilli (cif mtDNA biomarker)

            Recruiting
            • Neurodegenerative Diseases
            • cif mtDNA biomarker
            • Pozzilli, Isernia, Italy
              Stefano Gambardella
            Apr 27, 2022

            Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia

            Suspended
            • Polycystic Ovary Syndrome
            • +2 more
            • Phenotype/genotype assessment
            • Charlottesville, Virginia
              Center for Research in Reproduction
            May 16, 2022

            Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

            Recruiting
            • Pediatric Solid Tumor
            • +15 more
            • Memphis, Tennessee
              St. Jude Children's Research Hospital
            Jun 30, 2022

            Circulating Tumor DNA in Surgical Patients With Lung Cancer

            Active, not recruiting
            • Lung Cancer
              • Chengdu, Sichuan, China
                West China Hospital, Sichuan University
              Oct 12, 2022